CollPlant Biotechnologies (CLGN) Gains from Investment Securities (2021 - 2025)

CollPlant Biotechnologies' Gains from Investment Securities history spans 5 years, with the latest figure at $22000.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 12.0% year-over-year to $22000.0; the TTM value through Dec 2025 reached $22000.0, down 12.0%, while the annual FY2025 figure was $22000.0, 12.0% down from the prior year.
  • Gains from Investment Securities reached $22000.0 in Q4 2025 per CLGN's latest filing, down from $25000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $217000.0 in Q4 2022 to a low of $22000.0 in Q4 2025.
  • Average Gains from Investment Securities over 5 years is $89000.0, with a median of $25000.0 recorded in 2024.
  • Peak YoY movement for Gains from Investment Securities: surged 843.48% in 2022, then tumbled 84.18% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at $23000.0 in 2021, then soared by 843.48% to $217000.0 in 2022, then dropped by 27.19% to $158000.0 in 2023, then crashed by 84.18% to $25000.0 in 2024, then decreased by 12.0% to $22000.0 in 2025.
  • Per Business Quant, the three most recent readings for CLGN's Gains from Investment Securities are $22000.0 (Q4 2025), $25000.0 (Q4 2024), and $158000.0 (Q4 2023).